Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Inhibiting STAT1 Signaling and MHC Class I Expression. (jci.org)

Authors: Theivanthiran B … Hanks BA Journal: Journal of Clinical Investigation Published: 2026-08-13 DOI: https://doi.org/10.1172/JCI201816